Clinical Trial Update: A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral ixazomib with lenalidomide and dexamethasone versus placebo with lenalidomide and dexamethasone in relapsed/refractory multiple mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: Takeda | Conditions: Relapsed Multiple Myeloma, Refractory Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2016-01-27